About
Genomic Diagnostics
GeneSort is a molecular diagnostics company focused on integrating molecular genomics with personalized therapeutic approaches. The company's mission is to use patients' genetic DNA profile to assist physicians in selecting safe, effective, tailored treatments. GeneSort is focused on providing diagnostic services in the areas of cancer and hereditary diseases. The company has been acquired in July 2018 by Hong Kong investment fund AID Partners for $23 million.
Identity
| Name | GeneSort |
|---|---|
| Slug | genesort |
| Type / kind | startup |
| Crunchbase ID | genesort-ltd |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgPGJs5AKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by AID Partners on May 2017 - closed due to acquisition |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | Prof. Menakhem Plaut St 10, Rehovot, Israel |
Web & social
| https://www.linkedin.com/company/4852006 | |
| https://www.facebook.com/genesort |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
ConsumersDemographics & FamilyWomenEducation & AcademiaHealthcare & Life SciencesHealthcareInsurance CompaniesProvidersLaboratories
Business models
B2BB2G
Tags
genomicsmedical-technologiesbioinformaticscancerdiagnosticsearly-detectiononcologywomen-healthtargeted-therapylaboratorieshospitalsacademiainsurance-companiespersonalized-medicine
Funding
| Total raised | $2.2M |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}